Jonathan A. Bernstein, MD

Jonathan A. Bernstein, MD, is an adjunct professor, Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, at the University of Cincinnati College of Medicine. He is also a partner of the Bernstein Allergy Group and the Bernstein Clinical Research Center. He received his MD from the University of Cincinnati College of Medicine (1981-1985), completed his residency in internal medicine at the Cleveland Clinic Hospital (1985-1988), and received his allergy/clinical immunology training at Northwestern University (1988-1990). He has been a faculty member of the University of Cincinnati since 1990.

Dr Bernstein is the immediate past president of the American Academy of Allergy, Asthma & Immunology (AAAAI). He is also a member of the AAAAI and the American College of Allergy, Asthma & Immunology (ACAAI) Joint Task Force on Practice Parameters; the World Allergy Organization (WAO) Board of Directors; the Global Asthma Association (GAA)–INTERASMA Board of Directors; the Global Initiative for Asthma (GINA) Advocacy Council; and the Hereditary Angioedema Association (HAEA) Medical Advisory Board. He is a member of the University of Cincinnati College of Medicine Alpha Omega Alpha chapter.

Dr Bernstein is a Drug Information Association (DIA)–certified clinical trial investigator and conducts multicenter and physician-initiated clinical therapeutic trials related to asthma, chronic obstructive pulmonary disease (COPD), rhinitis, urticaria, atopic dermatitis, chronic cough, and hereditary and ACE inhibitor–induced angioedema. He has a spectrum of research interests that include allergic skin diseases, notably chronic urticaria, angioedema (eg, hereditary, acquired, and nonhistaminergic), atopic dermatitis, mast cell disorders (eg, systemic mastocytosis and hereditary alpha tryptasemia) chronic cough, severe asthma and asthma/COPD overlap, chronic rhinitis subtypes, and chronic rhinosinusitis with and without nasal polyps and immunodeficiencies. He also has expertise in food and drug allergies, environmental impact on allergic diseases, seminal plasma hypersensitivity, progesterone hypersensitivity, neuroimmune disorders such as dysautonomia and idiopathic autoimmune encephalitis, and other complex, unexplained conditions.

He was the editor in chief of the Journal of Asthma from 2009 to 2022 and is currently on the editorial board for The Journal of Allergy Clinical Immunology and Allergy & Asthma Proceedings. Dr Bernstein also serves as a reviewer for several allergy and immunology journals on a regular basis. He is currently an author or coauthor of 465 peer-reviewed articles and more than 40 book chapters, and he is the editor of 5 books pertaining to asthma, rhinitis, and immunodeficiency.

Dr Bernstein is actively involved with the University of Cincinnati Allergy/Immunology Fellowship Training Program in the education of fellows, residents, and medical students. He is the director or codirector of several centers of excellence, including the WAO Centers of Excellence, the American Initiative in Mast Cell Diseases (AIM), the Urticaria Centers of Reference and Excellence (UCARE), the Angioedema Centers of Reference and Excellence (ACARE), the Atopic Dermatitis Centers of Reference and Excellence (ADCARE), and the Anaphylaxis Centers of Reference and Excellence (ANACARE).

Dr Bernstein is the recipient many awards, including the Distinguished Clinician Award from the AAAAI and the WAO (2019). He has been voted “Best Doctor” in Cincinnati by Cincinnati Magazine from 1999 to 2024, and he has been ranked by U.S. News & World Report as being in the top 1% of doctors in his specialty.